Has Ian Cote, MD received payments from drug or device companies?

Yes. Drug and device makers reported $231,051 in general payments to Ian Cote, MD across 439 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ian Cote, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ian Cote, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ian Cote, MD

Neurological Surgery · Miami, FLNPI 1457762221

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $181,831 of the $231,051 with a category attached, or 78.7%. 16 manufacturers reported payments, led by Stryker at 48.2% of the total. Among neurological surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$231,051in general payments, 2019–2025

Across 439 payments — averaging $526.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$111K
Kyocera Medical Technologies, Inc.$100K
Globus Medical$16K
VB Spine LLC$2K
AstraZeneca$221
Altus Partners. LLC$179
plus $596 from 10 others

What the payments were for

Consulting fees$181,83179%
Travel & lodging$23,75910%
Food & beverage$25,46111%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	260	$111,323
Kyocera Medical Technologies, Inc.	10	$100,341
Globus Medical(2 entities)	128	$16,185
VB Spine LLC	23	$2,206
AstraZeneca	4	$221
Altus Partners. LLC	1	$179
Alphatec Spine, Inc	1	$172
Kls-martin L.p.	2	$159
Orthofix Medical, Inc.	2	$84
Axogen	1	$47
Baxter Healthcare	2	$34
Medtronic	1	$25
Neurocrine Biosciences, Inc.	1	$22
Pacira Pharmaceuticals Incorporated	1	$21
Integra Lifesciences Corporation	1	$17
Boston Scientific	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRITANIUM$28,199
ES2$26,611
ES2 SPINAL SYSTEM$25,026
CASCADIA INTERBODY SYSTEM$21,921
XIA$21,571
AIRO$20,800
NIAGARA LATERAL ACCESS SYSTEM$20,800
MONTEREY AL$20,800
SERRATO$19,260
MAKO$13,734
CASCADIA$12,970
CORE$11,538
SPINEJACK$8,000
XLIF$7,777
AERO$6,750
ARIA$6,188
LATERAL ACCESS SPINAL SYSTEM$6,100
AERO-LL$3,906
ALIF$2,572
EVEREST SPINAL SYSTEM$2,188

How this compares

$231,051 in reported general payments places this provider in the 90th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$210,771

Medicare patients

171

Services billed

507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	107	$3,128
Gabapentin	103	$1,402
Pregabalin	35	$623
Cyclobenzaprine Hcl	51	$513
Tizanidine Hcl	21	$424
Baclofen	25	$304
Methylprednisolone	34	$218
Diclofenac Sodium	16	$204
Duloxetine Hcl	12	$144
Meloxicam	11	$17

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Miami

Eric PetersonMiami$10.1M
Michael WangMiami$2.2M
Wilson AsforaMiami$1.3M
Steven VanniMiami$1.1M
Timur UrakovMiami$652K
Samuel GoldsmitMiami$519K
Robert StarkeMiami$302K
Michael IvanMiami$225K
James GuestMiami$155K
Stephen ParkerJacksonville$18.7M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →